Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
The FDA grants ODD status to medicines and potential new medicines intended for the treatment, diagnosis or prevention of rare diseases or disorders that affect fewer than 200,000 people in the US
Krivida Novus can detect the Omicron variant and its sub-lineages in 45 minutes
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
KardiaMobile is the first personal ECG to be recommended by NICE for use within the National Health Service (NHS) in England and Wales
Product candidates will be based on BioNTech’s proprietary mRNA technology and on Pfizer’s antigen technology. Clinical trials are expected to start in the second half of 2022
BPZE1 is the most advanced next-generation pertussis vaccine currently in clinical development
The first pilot study from India analyzing Covaxin-Covishield mixed doses
The Subject Expert Committee has recommended grant of permission to conduct Phase 3 trials under certain conditions
The company will market it under the brand name Molflu
Subscribe To Our Newsletter & Stay Updated
